Ketamine Test Evidence
Depends on the Brand of Test
Quetiapine
Source Liu et al., J Formos Med Assoc 2017
What It Found
- Two patients taking quetiapine screened positive for ketamine, and both results failed confirmation.
Keep in Mind
- The case report abstract does not identify the screen or establish that quetiapine caused the signal.
Test Studied
- Urine ketamine screen in a two-patient report
Source ARK Ketamine II Assay. Export package insert, revision 4, 2026
What It Found
- In a separate manufacturer study, urine spiked with quetiapine tested negative on ARK Ketamine II at both cutoffs.
Keep in Mind
- ARK tested 100,000 ng/mL of quetiapine at ketamine cutoffs of 50 and 100 ng/mL.
Test Studied
- ARK Ketamine II laboratory testing
The Test Is Made to Find It
Ketamine
Source Adamowicz and Kala, J Anal Toxicol 2005
What It Found
- After children received ketamine for anesthesia, investigators detected ketamine and norketamine in urine.
Keep in Mind
- A ketamine-positive urine result alone cannot distinguish medical from other exposure.
Test Studied
- Targeted urine ketamine and norketamine testing by GC-MS and LC-MS
Source ARK Ketamine II Assay. Export package insert, revision 4, 2026
What It Found
- The ARK screening assay also responds to norketamine and dehydronorketamine.
Test Studied
- ARK Ketamine II urine immunoassay
Source Harun et al., J Anal Toxicol 2009
What It Found
- Norketamine at 200 ng/mL exhibited 2.1% cross-reactivity in the ketamine assay.
- Ketamine and its metabolite were identified in 34 tested urine specimens.
Keep in Mind
- The ketamine screen responds predominantly to parent drug on this reagent.
Test Studied
- Neogen ketamine urine microplate ELISA, compared with LC-MS/MS
2 sources ARK Ketamine II Assay. Export package insert, revision 4, 2026 Harun et al., J Anal Toxicol 2009
Keep in Mind
- The contribution of each metabolite depends on the test.
Esketamine
Source ARK Ketamine II Assay. Export package insert, revision 4, 2026
What It Found
- Esketamine is the S form of ketamine.
- In spiked urine, 2,000 and 4,000 ng/mL of S-ketamine reached the respective 50 and 100 ng/mL assay cutoffs.
- The manufacturer measured 2.5% reactivity for S-ketamine at both cutoffs.
Keep in Mind
- The experiment tested the parent drug in urine.
- It cannot predict the result after a particular nasal dose or account for all urinary metabolites.
Test Studied
- ARK Ketamine II urine immunoassay, 50 and 100 ng/mL cutoffs
Tested: No False Positive Found
Amphetamine
Source Harun et al., J Anal Toxicol 2009
What It Found
- The tested Amphetamine challenge produced no response at 10,000 ng/mL.
Keep in Mind
- The paper identifies the standard as amphetamine without specifying an isomer or testing a marketed formulation.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
Cocaine (medical topical use)
Source Harun et al., J Anal Toxicol 2009
What It Found
- Both cocaine and benzoylecgonine showed no cross-reactivity at 10,000 ng/mL in the Neogen ketamine assay.
Keep in Mind
- These were chemical standards.
- The study did not test urine following topical medical cocaine administration.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
Dextromethorphan
Source ARK Ketamine II Assay. Export package insert, revision 4, 2026
What It Found
- Urine spiked with dextromethorphan at 100,000 ng/mL remained negative at both ketamine cutoffs in the manufacturer’s testing.
Keep in Mind
- The finding concerns the parent compound on this ketamine assay.
- Results on a phencyclidine (PCP) screen are a separate question.
Test Studied
- ARK Ketamine II urine immunoassay, 50 and 100 ng/mL cutoffs
Diazepam
Source Harun et al., J Anal Toxicol 2009
What It Found
- The tested Diazepam challenge produced no response at 10,000 ng/mL.
Keep in Mind
- The result applies to this ketamine ELISA and the specified compound or metabolite.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
Heroin
Source Harun et al., J Anal Toxicol 2009
What It Found
- The tested heroin metabolite, 6-monoacetylmorphine, showed no cross-reactivity at 10,000 ng/mL.
Keep in Mind
- Only the heroin metabolite 6-acetylmorphine (6-MAM) was tested.
- The experiment gives no direct result for the parent drug.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
Lamotrigine
Source ARK Ketamine II Assay. Export package insert, revision 4, 2026
What It Found
- Urine spiked with lamotrigine at 100,000 ng/mL remained negative at both ketamine cutoffs in the manufacturer’s testing.
Keep in Mind
- The finding concerns the parent compound on this ketamine assay.
- Results on a phencyclidine (PCP) screen are a separate question.
Test Studied
- ARK Ketamine II urine immunoassay, 50 and 100 ng/mL cutoffs
MDA
Source Harun et al., J Anal Toxicol 2009
What It Found
- The tested MDA challenge produced no response at 10,000 ng/mL.
Keep in Mind
- The result applies to this ketamine ELISA and the specified compound or metabolite.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
MDEA
Source Harun et al., J Anal Toxicol 2009
What It Found
- The tested MDEA challenge produced no response at 10,000 ng/mL.
Keep in Mind
- The result applies to this ketamine ELISA and the specified compound or metabolite.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
MDMA
Source Harun et al., J Anal Toxicol 2009
What It Found
- The tested MDMA challenge produced no response at 10,000 ng/mL.
Keep in Mind
- The result applies to this ketamine ELISA and the specified compound or metabolite.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
Methadone
Source Harun et al., J Anal Toxicol 2009
What It Found
- The tested Methadone challenge produced no response at 10,000 ng/mL.
Keep in Mind
- The result applies to this ketamine ELISA and the specified compound or metabolite.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
Methamphetamine
Source Harun et al., J Anal Toxicol 2009
What It Found
- Methamphetamine showed no cross-reactivity at 10,000 ng/mL in the Neogen ketamine assay.
Keep in Mind
- The result applies to this ketamine ELISA and the specified compound or metabolite.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
Morphine
Source Harun et al., J Anal Toxicol 2009
What It Found
- The tested Morphine challenge produced no response at 10,000 ng/mL.
Keep in Mind
- The result applies to this ketamine ELISA and the specified compound or metabolite.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
Phencyclidine
Source Harun et al., J Anal Toxicol 2009
What It Found
- The tested Phencyclidine challenge produced no response at 10,000 ng/mL.
Keep in Mind
- The result applies to this ketamine ELISA and the specified compound or metabolite.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
Tiletamine
Source Harun et al., J Anal Toxicol 2009
What It Found
- The tested Tiletamine challenge produced no response at 10,000 ng/mL.
Keep in Mind
- The result applies to this ketamine ELISA and the specified compound or metabolite.
Test Studied
- Neogen ketamine microplate urine ELISA, study specificity challenge
Venlafaxine
Source ARK Ketamine II Assay. Export package insert, revision 4, 2026
What It Found
- Urine spiked with venlafaxine at 100,000 ng/mL remained negative at both ketamine cutoffs in the manufacturer’s testing.
Keep in Mind
- The finding concerns the parent compound on this ketamine assay.
- Results on a phencyclidine (PCP) screen are a separate question.
Test Studied
- ARK Ketamine II urine immunoassay, 50 and 100 ng/mL cutoffs